Skip to main content
. 2017 Apr 5;8(24):39218–39229. doi: 10.18632/oncotarget.16836

Figure 3. Inhibition of Btk function in macrophages significantly compromises adhesion, invasion, and migration of lymphoid malignant cells.

Figure 3

(A) Lymphoid malignant cells were subjected to adhesion assays in conditioned medium collected from control and Btk inhibitor-treated (0.2, 0.5, 1, 2, 5 μM) macrophages. The adherent cells were measured by CellTiter-Glo luminescent cell viability assay. (B & C) Migration and invasion of tumor cells were analyzed in transwell plates, and supernatant from macrophages was added into the lower chamber as a chemoattractant. *Significantly decreased compared to LPS treatment alone (p < 0.05). Results are representative of three similar experiments.